June 23, 2015
RegMed’s still woozy from Friday’s witching hang over
June 23, 2015
Higher open expected; RegMed, do we feel lucky
June 22, 2015
RegMed, who’s sitting at the trading table? Approach the rest of the week with caution
June 22, 2015
RegMed, don’t blink - we’re up on small volume
June 22, 2015
Histogenics (HSGX) New CFO
June 19, 2015
RegMed, quadruple witch rides the broom as Capricor (CAPR) drops -$0.38 to $4.80
June 18, 2015
RegMed, the good news – we’re up; the bad news – financings raise funds but, hammer investors
June 17, 2015
RegMed, where’s the value in a beaten down sector – locked in the evidence room!
June 16, 2015
RegMed, execution issues are eroding confidence in “some” management’s ability to navigate pricing sustainability
35 companies, 1 interpreter!
Insight, foresight and recommendation
My motto … never leave an investor uninformed! I say today what others won’t, so you can do what others can’t.
My name is Henry McCusker; I endorse these opinions under my own name and with a subscription based membership.
Do you have an opinion you would like to share with us? We would like to hear from you.
Please e-mail us at hwm@regmedinvestors.com.
Editor and Publisher ... Henry McCusker enters his tenth (10th) year at RegMed Investors
© 2026 RegMed Investors (regmedinvestors.com), all rights are reserved.
RegMed Investors (RMi) or Regmedinvestors.com content is the intellectual property of Henry McCusker. Any copying, republication or redistribution of RMI’s content, including by framing or similar means, is expressly prohibited without the prior written consent of Scimitar; who also shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. For additional information on other Scimitar media services or reposting please email hwm@regmedinvestors.com.
The information included above as well as individual companies and/or securities mentioned should be construed as guidance in RMi reviews.
The facts stated and the opinions given in this publication are based on data and information considered to be reliable and have been carefully worked into my qualitative analyses and prognoses. However, no guarantee can be given as to their fairness, accuracy or completeness.
Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.